Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Prostate Cancer

  Free Subscription


24.06.2024

5 BJU Int
2 BMC Cancer
1 BMC Urol
1 Br J Cancer
2 Br J Radiol
1 Cancer
2 Cancer Lett
1 Eur Radiol
10 Eur Urol
1 Int J Cancer
1 J Natl Cancer Inst
1 Lancet Oncol
1 Magn Reson Imaging
1 Nat Rev Urol
2 Oncogene
3 Prostate
1 Urology


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BJU Int


  1. Pembrolizumab for the treatment of bladder and renal cancer and important new data concerning screening for prostate cancer.
    BJU Int. 2024;134:4-5.
    PubMed        

  2. KATO T, Matsumoto R, Yokomizo A, Tohi Y, et al
    Outcomes of active surveillance for Japanese patients with prostate cancer (PRIAS-JAPAN).
    BJU Int. 2024 Jun 17. doi: 10.1111/bju.16436.
    PubMed         Abstract available

  3. JUSSILA I, Ahtiainen JP, Laakkonen EK, Siltari A, et al
    Transdermal oestradiol and exercise in androgen deprivation therapy (ESTRACISE): protocol.
    BJU Int. 2024;134:110-118.
    PubMed         Abstract available

  4. SOPUTRO NA, Chavali JS, Ferguson EL, Ramos-Carpinteyro R, et al
    Complications of single-port robot-assisted radical prostatectomy: multi-institutional analysis from the Single-Port Advanced Research Consortium (SPARC).
    BJU Int. 2024;134:54-62.
    PubMed         Abstract available

  5. MORETTI TBC, Magna LA, Reis LO
    Continence criteria of 193 618 patients after open, laparoscopic, and robot-assisted radical prostatectomy.
    BJU Int. 2024;134:13-21.
    PubMed         Abstract available


    BMC Cancer

  6. YANG J, Xu Z, Zheng W, Li Y, et al
    Identification of the cytoplasmic DNA-Sensing cGAS-STING pathway-mediated gene signatures and molecular subtypes in prostate cancer.
    BMC Cancer. 2024;24:732.
    PubMed         Abstract available

  7. CI X, Chen S, Zhu R, Zarif M, et al
    Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer.
    BMC Cancer. 2024;24:744.
    PubMed         Abstract available


    BMC Urol

  8. BATHA O, Aldolly A, Alsaffaf Y, Hamsho S, et al
    Carcinoma in situ within the bladder trigone with an isolated metastasis to the prostate without involvement of prostatic urethra: a unique case report.
    BMC Urol. 2024;24:127.
    PubMed         Abstract available


    Br J Cancer

  9. ARMAKOLAS A, Alevizopoulos N, Stathaki M, Petraki C, et al
    Anti-PEc: Development of a novel monoclonal antibody against prostate cancer.
    Br J Cancer. 2024 Jun 20. doi: 10.1038/s41416-024-02713.
    PubMed         Abstract available


    Br J Radiol

  10. XIAO Y, Zeng Y, Han L, Lin G, et al
    A novel simplified transperineal prostate biopsy guided by perineal ultrasound.
    Br J Radiol. 2024 May 23:tqae097. doi: 10.1093.
    PubMed         Abstract available

  11. REINHARDT C, Briody H, MacMahon PJ
    AI-Accelerated prostate MRI: a systematic review.
    Br J Radiol. 2024 May 8:tqae093. doi: 10.1093.
    PubMed         Abstract available


    Cancer

  12. BASARIA S, Taplin ME, McDonnell M, Simonson DC, et al
    Insulin resistance during androgen deprivation therapy in men with prostate cancer.
    Cancer. 2024 Jun 16. doi: 10.1002/cncr.35443.
    PubMed         Abstract available


    Cancer Lett

  13. LIU C, Chen J, Cong Y, Chen K, et al
    PROX1 drives neuroendocrine plasticity and liver metastases in prostate cancer.
    Cancer Lett. 2024 Jun 18:217068. doi: 10.1016/j.canlet.2024.217068.
    PubMed         Abstract available

  14. CHEN HJ, Yu MM, Huang JC, Lan FY, et al
    SLC4A4 is a novel driver of enzalutamide resistance in prostate cancer.
    Cancer Lett. 2024 Jun 14:217070. doi: 10.1016/j.canlet.2024.217070.
    PubMed         Abstract available


    Eur Radiol

  15. PADHANI AR, Tunariu N, Perez-Lopez R, Tombal B, et al
    Evaluating prostate cancer bone metastases response with whole-body MRI: What we know and still need to know.
    Eur Radiol. 2024 Jun 20. doi: 10.1007/s00330-024-10864.
    PubMed        


    Eur Urol

  16. HU JC, Assel M, Allaf ME, Ehdaie B, et al
    Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial.
    Eur Urol. 2024;86:61-68.
    PubMed         Abstract available

  17. CHIU PK, Wu X, Gandaglia G
    Beyond Statistical Significance: Unveiling the Advantages of Transperineal Versus Transrectal Prostate Biopsies.
    Eur Urol. 2024;86:e16-e17.
    PubMed        

  18. GIANNAKODIMOS I
    Re: Jim C. Hu, Melissa Assel, Mohamad E. Allaf, et al. Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial. Eur Urol. 2024;86:61-68.
    Eur Urol. 2024;86:e12.
    PubMed        

  19. ROSEN GH, Chakiryan NH, Murray KS
    Re: Jim C. Hu, Melissa Assel, Mohamad E. Allaf, et al. Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial. Eur Urol. 2024;86:61-68.
    Eur Urol. 2024;86:e14.
    PubMed        

  20. HU JC, Schaeffer EM, Vickers AJ
    Reply to Ilias Giannakodimos' Letter to the Editor re: Jim C. Hu, Melissa Assel, Mohamad E. Allaf, et al. Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREV
    Eur Urol. 2024;86:e13.
    PubMed        

  21. MACEK P, Rodriguez-Sanchez L, Cathelineau X
    Re: Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of
    Eur Urol. 2024 Jun 13:S0302-2838(24)02401-1. doi: 10.1016/j.eururo.2024.
    PubMed        

  22. RAYCHAUDHURI R, DeJong M, Rettig M, Yu EY, et al
    Docetaxel and Carboplatin for the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer and Biallelic Inactivation of Genes in the Homologous Recombination DNA Repair Pathway: The ABCD Trial.
    Eur Urol. 2024 Jun 17:S0302-2838(24)02407-2. doi: 10.1016/j.eururo.2024.
    PubMed        

  23. SRIVASTAVA A, Lewicki P, Morgan TM
    Biomarkers in Prostate Cancer Screening: Sometimes "More is More".
    Eur Urol. 2024 Jun 18:S0302-2838(24)02428-X. doi: 10.1016/j.eururo.2024.
    PubMed        

  24. COOPERBERG MR
    PRECISE v2: An Enhanced Framework To Guide Future Research on the Use of Magnetic Resonance Imaging in Prostate Cancer Active Surveillance.
    Eur Urol. 2024 Jun 18:S0302-2838(24)02400-X. doi: 10.1016/j.eururo.2024.
    PubMed        

  25. TANEJA SS
    Reducing or Increasing Overtreatment? How Do We Measure the Impact of Magnetic Resonance Imaging-targeted Biopsy on Prostate Cancer Mortality?
    Eur Urol. 2024 Jun 19:S0302-2838(24)02413-8. doi: 10.1016/j.eururo.2024.
    PubMed        


    Int J Cancer

  26. SEE AW, Conway P, Frydenberg M, Haxhimolla H, et al
    Five-year outcomes of fractionated stereotactic body radiotherapy for oligometastatic prostate cancer from the TRANSFORM phase II trial.
    Int J Cancer. 2024 Jun 19. doi: 10.1002/ijc.35052.
    PubMed         Abstract available


    J Natl Cancer Inst

  27. DING CC, Tony Su Z, Erak E, DePaula Oliveira L, et al
    Predicting prostate cancer grade reclassification on active surveillance using a deep Learning-Based grading algorithm.
    J Natl Cancer Inst. 2024 Jun 18:djae139. doi: 10.1093.
    PubMed         Abstract available


    Lancet Oncol

  28. SAHA A, Bosma JS, Twilt JJ, van Ginneken B, et al
    Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study.
    Lancet Oncol. 2024 Jun 11:S1470-2045(24)00220.
    PubMed         Abstract available


    Magn Reson Imaging

  29. WONG OL, Yuan J, Poon DMC, Chiu ST, et al
    Prostate diffusion-weighted imaging (DWI) in MR-guided radiotherapy: Reproducibility assessment on 1.5?T MR-Linac and 1.5?T MR-simulator.
    Magn Reson Imaging. 2024 Mar 18:S0730-725X(24)00076.
    PubMed         Abstract available


    Nat Rev Urol

  30. MADAN RA, Posadas EM, Lee RJ
    Progression-free survival end points in prostate cancer: are we truly making progress.
    Nat Rev Urol. 2024 Jun 17. doi: 10.1038/s41585-024-00902.
    PubMed        


    Oncogene

  31. CHEN B, Xu P, Yang JC, Nip C, et al
    Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancer.
    Oncogene. 2024 Jun 14. doi: 10.1038/s41388-024-03081.
    PubMed         Abstract available

  32. LIN G, Zhang F, Weng X, Hong Z, et al
    Role of gut microbiota in the pathogenesis of castration-resistant prostate cancer: a comprehensive study using sequencing and animal models.
    Oncogene. 2024 Jun 17. doi: 10.1038/s41388-024-03073.
    PubMed         Abstract available


    Prostate

  33. CORDOBA SANCHEZ J, Monge-Escartin I, Gil J, Carrera C, et al
    Real-world study: Impact of multidisciplinary management of apalutamide-associated adverse events in prostate cancer.
    Prostate. 2024 Jun 18. doi: 10.1002/pros.24755.
    PubMed         Abstract available

  34. MALSHY K, Ochsner A, Homer A, Allu S, et al
    Consistent predictive ability of prostate-specific antigen density prediction model for clinically significant prostate cancer across age strata.
    Prostate. 2024 Jun 20. doi: 10.1002/pros.24757.
    PubMed         Abstract available

  35. PRAKASH P, Verma S, Gupta S
    Influence of microbiome in intraprostatic inflammation and prostate cancer.
    Prostate. 2024 Jun 20. doi: 10.1002/pros.24756.
    PubMed         Abstract available


    Urology

  36. GARCIA ROJO E
    Reply to Letter to the Editor on "Comparison in Detection Rate of Clinically Significant Prostate Cancer Between Microultrasound-guided Prostate Biopsy (ExactVu) and Multiparametric Resonance Imaging-guided Prostate Biopsy (Koelis System)".
    Urology. 2024 Jun 12:S0090-4295(24)00459-X. doi: 10.1016/j.urology.2024.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.